Valuation: Photocure ASA

Market Cap 1.55B 156M 137M 126M 117M 222M 14.83B 226M 1.52B 587M 7.28B 586M 573M 25.33B P/E 2026 *
16.9x
P/E 2027 * 34.4x
Enterprise Value 1.3B 132M 116M 106M 99.08M 187M 12.51B 191M 1.28B 495M 6.14B 494M 483M 21.37B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.94x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week-2.01%
Current month-1.18%
1 month-2.01%
3 months+0.86%
6 months-18.50%
Current year-17.93%
1 week 57.6
Extreme 57.6
61.8
1 month 56.2
Extreme 56.2
63.5
Current year 55.2
Extreme 55.2
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25BuyCompany 8,997 0.0332%
02/04/25BuyCompany 11,355 0.0419%
31/03/25BuyCompany 26,492 0.0977%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%-2.01%+5.78%+23.76% 156M
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.72%-0.96%+26.12%+20.22% 324B
+1.70%+0.26%+35.69%+35.90% 285B
+0.76%+0.11%+28.15%+42.47% 283B
-0.56%+2.09%-27.01%-40.47% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.31%+2.23%+25.45%+50.20% 358.08B
Weighted average by Cap. +0.07%+4.16%+38.30%+77.33%

Financials

2026 *2027 *
Net sales 658M 66.4M 58.3M 53.66M 50M 94.3M 6.31B 96.22M 645M 250M 3.1B 249M 244M 10.78B 663M 66.9M 58.74M 54.07M 50.38M 95.02M 6.36B 96.95M 650M 252M 3.12B 251M 246M 10.87B
Net income 92.33M 9.32M 8.18M 7.53M 7.02M 13.23M 886M 13.5M 90.56M 35.09M 435M 34.98M 34.23M 1.51B 45M 4.54M 3.99M 3.67M 3.42M 6.45M 432M 6.58M 44.14M 17.1M 212M 17.05M 16.68M 737M
Net Debt -242M -24.42M -21.44M -19.73M -18.39M -34.68M -2.32B -35.39M -237M -91.97M -1.14B -91.69M -89.7M -3.97B -263M -26.5M -23.27M -21.42M -19.96M -37.64M -2.52B -38.41M -258M -99.82M -1.24B -99.52M -97.37M -4.3B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
02/07/26 NOK 58.60 +0.86% 3,851
01/07/26 NOK 58.10 -2.02% 55,585
30/06/26 NOK 59.30 -1.33% 19,305
29/06/26 NOK 60.10 -1.15% 53,101
26/06/26 NOK 60.80 +1.67% 13,361
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
58.10NOK
Average target price
84.00NOK
Spread / Average Target
+44.58%

Quarterly revenue - Rate of surprise